Stifel raises ORIC Pharmaceuticals target price to $18 from $14
ORIC•Stifel raised its target price for ORIC Pharmaceuticals to $18 from $14.
Related News
Coincheck Group publishes update to financial calendar
CNCK•
ASP Isotopes says Renergen’s Virginia gas project achieves stable liquid helium production
ASPI•
Apple, Kaiser Aluminum, Reliance in US research roundup
AAPL•
U.S. stocks on the move: Verizon, Surgery Partners
VZ•
Bernstein boosts Eli Lilly price target on international Mounjaro strength
LLY•